scorecardresearch
Wednesday, October 16, 2024
Support Our Journalism
HomeIndiaFormer MP says multinational firm's intraocular lens turns opaque, seeks Mandaviya's intervention

Former MP says multinational firm’s intraocular lens turns opaque, seeks Mandaviya’s intervention

Follow Us :
Text Size:

New Delhi, Jun 20 (PTI) A former MP, who is an eye surgeon, has written to Union Health Minister Mansukh Mandaviya expressing concerns about the quality of intraocular lenses (IOLs) manufactured by a multinational company for cataract surgery. Dr Vikas Mahatme has sought Mandaviya’s intervention so that stringent action can be taken against the firm.

“I wish to bring to your kind notice a serious problem with Alcon, a multinational company that manufactures IOLs for cataract surgery. I have implanted it in one of my patients, Sanjay Bhalme. It is expected that the lens which is implanted must remain transparent for the rest of life of the patient,” the former Rajya Sabha MP said in his letter.

He said that on May 9, 2016, he implanted Alcon IOL in the patient’s right eye.

“To my utter surprise, this IOL has gone opaque now. I was shocked to see this when patient came to me in November 2022. He has diminished quality of vision. He cannot see if the light comes from the front side. Unfortunately, his Left eye is already blind and now he has compromised vision in the right eye too.  “He is quite depressed and frustrated with this event. Thereafter, I raised my concern with Alcon. However, their attitude was very casual and careless,” Dr Mahatme said.

He said he had a video conference meeting with the Alcon team and alleged “they were not at all sensitive about this issue”.

“They can do this only in India. Had it been any western country, they would have paid a huge compensation,” the doctor said.

“I am also concerned that similar problem may occur in other patients and may create a disaster for them. To avoid this and also to compensate for the vision of the patient, I seek your intervention in this matter so that stringent action should be taken against the company. This will ensure that no more patients are affected in this way,” Dr Mahatme stated. PTI PLB KVK KVK

This report is auto-generated from PTI news service. ThePrint holds no responsibility for its content.

Subscribe to our channels on YouTube, Telegram & WhatsApp

Support Our Journalism

India needs fair, non-hyphenated and questioning journalism, packed with on-ground reporting. ThePrint – with exceptional reporters, columnists and editors – is doing just that.

Sustaining this needs support from wonderful readers like you.

Whether you live in India or overseas, you can take a paid subscription by clicking here.

Support Our Journalism

  • Tags

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular